Summary of Key Points Core Viewpoint The company, Ruikang Pharmaceutical Group Co., Ltd., has revised its Articles of Association and certain governance systems, which will be submitted for shareholder approval. The revisions are in accordance with relevant laws and regulations, reflecting the company's actual situation. Group 1: Revision of Articles of Association - The company has made amendments to its Articles of Association based on the Company Law of the People's Republic of China and other relevant regulations [1][2][3] - The revised Articles of Association will be submitted for approval at the upcoming shareholders' meeting [1][2] - The updated Articles of Association have been published on the official website for public access [1] Group 2: Governance Structure Changes - The legal representative of the company will be the director responsible for executing company affairs, and the resignation of the legal representative will require the appointment of a new representative within thirty days [2][3] - The company will bear civil liability for the legal activities conducted by its legal representative, and may seek compensation from the representative if there is fault [2][3] - The company’s governance structure aims to ensure compliance and operational efficiency, enhancing shareholder value and corporate responsibility [4][5]

Core Points - The legal opinion letter confirms the legality of the convening and holding of the 2025 first extraordinary general meeting of Huayang Group Co., Ltd. [2][5] - The meeting was convened by the company's board of directors and took place on September 5, 2025, with a combination of on-site and online voting [3][4] - A total of 210 shareholders and their proxies attended the meeting, representing 308,962,945 shares, which is 58.8592% of the total shares with voting rights [4][5] Meeting Procedures - The meeting notice was announced on August 20, 2025, detailing the time, location, agenda, and participation methods [3] - Voting was conducted both on-site and through an online platform provided by the Shenzhen Stock Exchange [3][4] - The meeting was presided over by the chairman, Mr. Zou Ganrong [3] Attendance and Voting - 7 shareholders attended the meeting in person, representing 303,621,241 shares (57.8415% of the total) [4] - 203 shareholders participated via online voting, representing 5,341,704 shares (1.0176% of the total) [4] - The meeting included company directors, supervisors, and senior management, all of whom were present or attended the meeting [4] Voting Results - A total of 6 proposals were presented for voting, all of which were approved [5][6] - The voting results showed significant support for the proposals, with the majority receiving over 99% approval from the attending shareholders [6][9] - The voting process was supervised by shareholder representatives, supervisor representatives, and the law firm, ensuring compliance with relevant laws and regulations [5][9] Conclusion - The legal opinion concludes that the convening and holding of the meeting, as well as the qualifications of the conveners and attendees, comply with the Company Law and relevant regulations [9]

Meeting Information - The shareholders' meeting of Qijing Machinery Co., Ltd. is scheduled for September 23, 2025, at 14:30 [1] - The meeting will be held at the company's office building in Ninghai County, Zhejiang Province [1] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's voting system [1] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's online voting system from 9:15 to 15:00 on the day of the meeting [1][2] - Shareholders holding multiple accounts can aggregate their voting rights across all accounts [3] - Votes exceeding the number of shares owned will be considered invalid [4] Attendance and Registration - Shareholders registered by the close of trading on September 17, 2025, are eligible to attend the meeting [4] - Both natural and legal person shareholders must complete specific registration procedures to attend [4] Proxy Voting - Shareholders can appoint proxies to attend and vote on their behalf, with specific documentation required for both natural and legal person shareholders [4][6] Cumulative Voting System - The meeting will utilize a cumulative voting system for the election of directors and independent directors, allowing shareholders to allocate their votes as they see fit [7][8]

Meeting Details - The meeting was held on September 5, 2025, at 14:30, with both on-site and online voting options available [1] - A total of 210 shareholders and their representatives attended, representing 308,962,945 shares, which is 58.8592% of the total voting shares [2] - The meeting was convened by the company's board of directors and presided over by Chairman Zou Ganrong [1][2] Voting Results - The voting process combined on-site and online methods, with a total of 308,837,645 shares voting in favor of the proposals, accounting for 99.9594% of the valid votes [2] - The proposals received overwhelming support from minority shareholders, with 98.1064% voting in favor [2] - Multiple proposals were passed with similar high approval rates, with some reaching over 99.96% in favor [3][4][5][6][7] Board Elections - The meeting elected Zou Ganrong and other members to the fifth board of directors, with Zou receiving 99.5752% of the votes [7] - Other board members elected included Lin Yuanhui, Zhang Yuanzhe, Wu Wei, Li Daoyong, and Sun Yongdi, all receiving over 99.5% approval [8][9][10] Legal Compliance - The meeting was witnessed by lawyers from Beijing Tongshang (Shenzhen) Law Firm, who confirmed that the meeting's procedures complied with relevant laws and regulations [10]

Meeting Details - The shareholders' meeting was held on September 5, 2025, at the company's office in Ningbo, Zhejiang Province [1] - The meeting was convened by the board of directors and chaired by Chairman Mei Xuhui, utilizing a combination of on-site and online voting methods [1] - The meeting's procedures and voting methods complied with the Company Law and the company's articles of association, ensuring its legality and validity [1] Voting Results - All proposed resolutions were approved with significant support from shareholders, with A-share votes showing high approval rates, such as 99.8836% for the first resolution [2] - The voting results for subsequent resolutions also reflected strong shareholder support, with approval rates consistently above 99.9% [2][3] - The total number of votes for the resolutions indicated a high level of engagement and consensus among shareholders [2][3] Legal Compliance - The meeting's convening and voting procedures were confirmed to be in accordance with legal regulations and the company's articles of association by the attending lawyers [3]

Core Viewpoint - The company is holding its second extraordinary general meeting of shareholders in 2025 to elect non-independent and independent directors for the fifth board of directors, as the term of the fourth board will expire on September 18, 2025 [1][11]. Group 1: Election of Non-Independent Directors - The controlling shareholder, Ningbo Industrial Investment Group Co., Ltd., has nominated four candidates for non-independent directors: Mei Xuhui, Wang Dongsheng, Li Hengsheng, and Miao Kai, while Ningbo Qijing Holdings Co., Ltd. has nominated Wang Weidong [2][6]. - The term for the elected non-independent directors will be three years from the date of approval by the shareholders' meeting [2]. - The nomination committee has confirmed that all candidates meet the qualifications as per relevant laws and regulations, and none have faced penalties or investigations in the last 36 months [2][5]. Group 2: Election of Independent Directors - The controlling shareholder has nominated Cao Yue as a candidate for independent director, while Ningbo Qijing Holdings Co., Ltd. has nominated two candidates: Dan Aidang and Pan Jun [11][12]. - The independent directors will also serve a term of three years from the date of approval by the shareholders' meeting [11]. - Similar to the non-independent candidates, the nomination committee has verified that the independent candidates meet all necessary qualifications and have not faced any legal issues in the past 36 months [12][15].

Group 1 - The company plans to acquire 71% of Qingdao Kekai Electronics Research Institute through a combination of issuing shares and cash payments, involving 23 counterparties [1][2] - The transaction is expected to be classified as a major asset restructuring under the regulations of the Management Measures for Major Asset Restructuring of Listed Companies, and it constitutes a related party transaction but does not qualify as a restructuring listing [1] - An asset appraisal report was issued by Shanghai Dongzhou Asset Appraisal Co., Ltd. as of December 31, 2024, and the company intends to adjust the transaction plan based on the appraisal results, which is not expected to constitute a major change to the plan [2] Group 2 - The company will continue to coordinate with all parties involved in the transaction and relevant intermediary institutions to advance the transaction process [2] - The completion of the transaction is subject to multiple conditions, including approval from the company's board of directors, review by the Shanghai Stock Exchange, and obtaining consent from the China Securities Regulatory Commission [2]

Summary of Key Points Core Viewpoint - 瑞康医药集团股份有限公司 has approved a proposal to provide guarantees for its subsidiaries, with a total guarantee limit not exceeding RMB 2 billion, aimed at ensuring smooth operational financing and enhancing management of external guarantees [1][2]. Group 1: Guarantee Overview - The company plans to provide guarantees for its subsidiaries, with a total limit of RMB 2 billion, including a maximum of RMB 1 billion for subsidiaries with a debt-to-asset ratio above 70% [1]. - The guarantees will cover various financing activities such as comprehensive credit applications, loans, and leasing [2]. - The actual guarantee amounts will be determined based on specific agreements and will not require additional board or shareholder meetings for approval within the set limits [2]. Group 2: Financial Risk Management - All guaranteed entities are within the company's consolidated financial statements, and the financial risks are considered manageable [2][3]. - As of the announcement date, the company has provided guarantees totaling RMB 545.20 million, representing 9.85% of the audited net assets attributable to the parent company for 2024 [3]. - The company has no overdue guarantees or any litigation related to guarantees as of the announcement date [3]. Group 3: Board of Directors' Opinion - The board believes that providing guarantees for wholly-owned and controlled subsidiaries is necessary for the company's operations and business development [3]. - The risks associated with these guarantees are deemed controllable, and there is no harm to the interests of the company or its shareholders, particularly minority shareholders [3].

Core Viewpoint - The company has decided to abolish the supervisory board and transfer its responsibilities to the audit committee of the board of directors, along with a comprehensive revision of its articles of association to align with current laws and regulations [1][2][3]. Summary by Sections Abolishment of Supervisory Board - The company will no longer have a supervisory board, with its powers being transferred to the audit committee of the board of directors [2]. - The decision was made during the first extraordinary general meeting of shareholders in 2025, and the current supervisors will no longer hold their positions [2]. Revision of Articles of Association - The articles of association have been revised to comply with the latest regulations, including the abolishment of the supervisory board [2]. - Key changes include the definition of the legal representative of the company and the responsibilities of the board of directors [3][4]. - The revised articles now clarify the rights and obligations of shareholders, directors, and senior management, ensuring legal binding [4][5]. Company Operations and Responsibilities - The company’s assets are divided into equal shares, and shareholders are liable only to the extent of their subscribed shares [4][5]. - The company is responsible for its debts with all its assets, and the articles of association serve as a binding document for all parties involved [4][5]. Shareholder Rights and Obligations - Shareholders have the right to request information, attend meetings, and participate in decision-making processes [12][13]. - The articles outline the procedures for shareholders to exercise their rights, including the ability to sue the company or its directors under certain conditions [12][13]. Capital Increase and Share Issuance - The company can increase its capital through various methods, including public offerings and private placements, as per the revised articles [10][11]. - The issuance of shares must adhere to principles of fairness and equality among shareholders [10][11]. Governance and Legal Compliance - The company is required to comply with laws and regulations regarding the governance structure and the rights of shareholders [20][21]. - The articles stipulate that any abuse of shareholder rights that harms the company or other shareholders will result in liability [20][21].

Core Points - The nominee, Ningbo Qijing Holdings Co., Ltd., has proposed a candidate for the independent director position on the fifth board of Qijing Machinery Co., Ltd. and has confirmed the candidate's qualifications and independence [1][2] - The nominee has ensured that the candidate possesses the necessary knowledge of listed company operations and has over five years of relevant work experience in law, economics, accounting, finance, or management [1] - The candidate meets the legal and regulatory requirements for independent directors as outlined in various Chinese laws and regulations [1][2] - The nominee has verified that the candidate does not have any relationships that could affect their independence, including not being a major shareholder or having significant business dealings with the company [1][2] - The candidate has no adverse records, such as administrative penalties or criminal charges from the China Securities Regulatory Commission (CSRC) in the last 36 months [2] - The nominee guarantees the accuracy and completeness of the statements made regarding the candidate's qualifications [3]